Psychiatry & Neurology Doctors in Wpafb, OH Accepting Medicare

6 Psychiatry & Neurology doctors found. Showing 1 - 6

Jessica Porcelan, MD Psychiatry & Neurology - Psychiatry Medicare: May Accept Medicare Assignments Practice Location: 4881 Sugar Maple Dr, Wpafb, OH 45433 Phone: 937-257-6877

Dr. Tyler Eldon Yorgason, DO Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 4881 Sugar Maple Dr, Wpafb, OH 45433 Phone: 372-570-8379

Alice A Hale, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 4881 Sugar Maple Dr, Sgoh, Wpafb, OH 45433 Phone: 937-257-6877    Fax: 937-986-1192

Stacy A Solheim, D.O. Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Not Enrolled in Medicare Practice Location: Wright Patterson Medical Center - 88 Mdos/sgow, 4881 Sugar Maple Ave, Wpafb, OH 45433 Phone: 937-257-6877

Dr. Matthew James Baker, D.O. Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 4881 Sugar Maple Dr, Wpafb, OH 45433 Phone: 937-257-6877    Fax: 937-656-1192

William Robert Clark, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 4881 Sugar Maple Dr, Wpafb, OH 45433 Phone: 937-257-6877

News Archive

USPTO terminates interference proceeding in favor of PDL's '089 Patent

PDL BioPharma, Inc. today announced that on December 15, 2010, the U.S. Patent and Trademark Office (the PTO) terminated its interference proceeding between certain claims of the Company's Queen et al., U.S. Patent No. 5,585,089, (the '089 Patent) and certain pending claims of Adair et al., U.S. Application No. 08/846,658, (the '658 Application) in favor of the Company's '089 Patent.

Mast Therapeutics begins vepoloxamer Phase 2 study in patients with chronic heart failure

Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company leveraging its molecular adhesion and sealant technology (MAST) platform to develop novel therapies for sickle cell disease, heart failure, and stroke, announced that it has initiated its Phase 2 study of vepoloxamer for the treatment of patients with chronic heart failure.

Exposure to toxin domoic acid might negatively affect unborn children

Duke University Medical Center researchers have found that the naturally occurring marine toxin domoic acid can cause subtle but lasting cognitive damage in rats exposed to the chemical before birth. Humans can become poisoned by the potentially lethal, algal toxin after eating contaminated shellfish.

Psychiatrist wins Kempf Fund Award for Research Development in Psychobiological Psychiatry

Dr. Peter F. Buckley, a psychiatrist specializing in schizophrenia and Dean of the Medical College of Georgia at Georgia Regents University, is the 2014 winner of the Kempf Fund Award for Research Development in Psychobiological Psychiatry from the American Psychiatric Association.

Alere, Leeds and Partners establish collaborative framework to improve outcomes within NHS

Alere Inc., a leading supplier of healthcare solutions, along with key partners in health and social care in Leeds, have established a collaborative framework thought to be the first of its kind in the UK, designed to achieve improved outcomes within the National Health Service.

Read more Medical News

› Verified 5 days ago